Examples
Worked examples
- Is an instance
A university's internal Proof-of-Concept (or 'gap') fund awards $15,000 to a faculty inventor with an existing invention disclosure to build a working prototype and complete a freedom-to-operate screen before the TTO decides whether to file a full patent application.
- Is an instance
A PI who holds an active ERC Consolidator Grant applies for an ERC Proof of Concept Grant to run technical validation and file a provisional patent on a diagnostic assay that emerged from the funded project, ahead of pursuing a licence or spinout -- see CASRAI's entry on the ERC Proof of Concept Grant for this specific named scheme.
- Is an instance
NIH's REACH (Research Evaluation and Commercialization Hubs) program funds proof-of-concept and commercialization support -- prototype development, market validation, mentoring -- for biomedical researchers whose results have already emerged from NIH-funded research.
Counter-examples
Looks similar, but isn't
- Not an instance
An early-career researcher receives an institutional seed grant to generate preliminary pilot data for a first extramural grant application -- this is seed funding, not proof-of-concept funding, because there is no existing discovery being tested for commercial or technical feasibility; the goal is to strengthen a future research proposal, not to de-risk a specific technology for licensing or investment.
- Not an instance
A start-up raises a pre-seed equity round from angel investors to build an initial product -- this is early-stage venture financing, not proof-of-concept funding, because it is dilutive (the investors take equity) and is not a milestone-based award administered by or alongside a research institution's TTO.
Editorial commentary
Proof-of-concept funding sits at a specific point in the research-to-commercialization pipeline: after a discovery has been made — and often after an invention disclosure has already been filed with a technology-transfer office (TTO) — but before that discovery is far enough along to support a licence, a spinout, or outside investment on its own. Its purpose is narrow and consistent across the many schemes that use the label: reduce technical and/or commercial risk on a specific, already-identified result, using milestone-based, typically non-dilutive funding, so that the technology is more attractive to a licensee, investor, or follow-on funder.
How proof-of-concept funding differs from seed funding
The two categories are often confused because both provide small, early awards, but they answer different questions and sit at different points in a research idea’s life:
- Seed funding asks: does this idea deserve initial support to generate the preliminary data or pilot results needed to compete for a larger research grant? It is typically awarded by institutions, learned societies, or research funders and is judged against research-progress criteria.
- Proof-of-concept funding asks: is this already-existing result — a finding, an invention, a prototype — technically and/or commercially viable enough to license, spin out, or attract outside investment? It typically requires a specific underlying discovery (often a filed invention disclosure) as the starting point, and progress is judged against technology-readiness or commercialization milestones rather than research-progress criteria.
A useful shorthand: seed funding helps a research idea become fundable; proof-of-concept funding helps an already-funded discovery become licensable, investable, or spinout-ready. See CASRAI’s seed funding entry for the earlier-stage mechanism, and the technology readiness level (TRL) entry for the milestone framework proof-of-concept programs frequently report against.
Where proof-of-concept funding comes from
Because the underlying need — de-risking a specific discovery before it can be licensed, spun out, or externally invested in — is common across research systems, proof-of-concept funding is offered under many different names and administrative structures rather than a single standardized program:
- Funder-run schemes tied to a prior award. The ERC Proof of Concept Grant is a well-documented example: a EUR 150,000, up-to-18-month top-up award, open only to principal investigators who currently hold or have held one of the European Research Council’s four main frontier-research grants, used specifically to explore the commercial or societal application potential of results already generated under that funded project.
- University-run internal funds, often called PoC funds, gap funds, or commercialization funds. Administered by or alongside the institution’s TTO, these typically require an existing invention disclosure, fund a small number of defined technical and business-development milestones (often in the low tens of thousands of dollars), and run on a fixed application-to-decision cycle of roughly a year or less.
- National/agency translational programs. In the US, NIH’s REACH (Research Evaluation and Commercialization Hubs) program funds proof-of-concept and early commercialization support — prototyping, market validation, mentoring — for results emerging from NIH-funded biomedical research; NSF’s I-Corps curriculum performs a related but distinct function, funding structured customer-discovery activity (a minimum number of stakeholder interviews) rather than technical prototype development itself. Most university PoC/gap funds and I-Corps are complementary rather than duplicative: many institutional PoC funds require or strongly recommend I-Corps completion first, since the customer-discovery evidence I-Corps produces often informs which technologies a PoC fund should prioritize.
See CASRAI’s guide on university innovation and accelerator programs for how these instruments — PoC/gap funds, I-Corps, REACH, and venture accelerators — typically fit together inside a single institution’s commercialization pipeline, and the guide on funding options for a university spinout for how proof-of-concept-stage outcomes typically feed into later spinout financing.
What proof-of-concept funding is typically used for
- Building or refining a working prototype to demonstrate technical feasibility beyond a laboratory-scale result
- Freedom-to-operate screening or provisional patent filing, often run in parallel with or immediately after the funded activity
- Market or stakeholder validation — structured interviews with potential licensees, industry partners, or investors
- Generating the specific data package a licensing negotiation or investor due-diligence process will ask for
Why the distinction matters for research administrators
Confusing the two categories has practical consequences. A researcher pointed toward a proof-of-concept fund when what they actually need is preliminary pilot data for a future grant application will find the eligibility criteria a poor fit — most PoC schemes explicitly require an existing invention or result as the starting point and will not fund open-ended exploratory research. Conversely, a TTO evaluating whether a technology is ready for a PoC award, rather than still needing basic seed-stage development, typically looks for signals such as a filed invention disclosure, a defined technical result, and a plausible commercialization or licensing pathway — the same signals that distinguish PoC funding from seed funding in the first place. Tracking which category a given internal or external funding opportunity actually falls into also matters for how an institution routes the application (research office versus TTO) and how the resulting award is classified in a research information system.
Related terms
Machine-readable encodings
Use in your systems
<role vocab="credit"
vocab-identifier="https://casrai.org/dictionary/"
vocab-term="Proof-of-Concept Funding"
vocab-term-identifier="https://casrai.org/dictionary/term/proof-of-concept-funding" />{
"@context": "https://schema.org",
"@type": "DefinedTerm",
"@id": "https://casrai.org/dictionary/term/proof-of-concept-funding",
"name": "Proof-of-Concept Funding",
"identifier": "https://casrai.org/dictionary/term/proof-of-concept-funding",
"description": "<p><strong>Proof-of-concept (PoC) funding</strong> is a category of small, milestone-based, non-dilutive awards used to test and demonstrate the technical and/or commercial feasibility of a discovery that has already been made -- bridging the gap between a research finding and a patentable, licensable, or investable technology. It is distinguished from earlier-stage <a href='/dictionary/term/seed-funding'>seed funding</a> by its purpose and starting point: PoC funding assumes a specific invention or result already exists (often already the subject of an invention disclosure or provisional patent filing) and uses the award to move that specific result forward -- validating a prototype, running freedom-to-operate or IP-strategy work, generating the data needed for a licensing conversation, or engaging early industry/investor interest -- rather than to generate the preliminary data needed to justify a larger research grant in the first place. PoC funding is typically administered by, or run in close coordination with, a university technology-transfer office (TTO), a national/regional funder's dedicated PoC scheme, or a translational funding agency, and award activity is usually reported against a technology readiness level (TRL) or an equivalent milestone framework rather than conventional research-progress metrics.</p>",
"inDefinedTermSet": "https://casrai.org/dictionary/domain/funding-finance#set",
"url": "https://casrai.org/dictionary/term/proof-of-concept-funding",
"sameAs": [],
"license": "https://creativecommons.org/licenses/by/4.0/",
"publisher": {
"@id": "https://casrai.org/#organization"
},
"dateModified": "2026-07-18T02:39:41",
"inLanguage": "en"
}
